Stocks
DermTech, Inc.DMTK
NASDAQHealthcareBiotechnology$0.09-11.32%
Focused on genomic skin cancer diagnostics, the company develops non‑invasive adhesive patch tests designed to detect melanoma and other skin conditions without surgical biopsy. Its flagship technology analyzes gene expression from skin samples collected through a patch, targeting dermatology practi...
Market Cap: $3.3M52W Range: $0.04 – $3.90
Congressional Interest in DermTech, Inc. (DMTK)
1 member of Congress has disclosed 3 trades in DermTech, Inc. (DMTK), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 1 sale, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
3
Unique Politicians
1
Buys
2
Sells
1
Who in Congress Is Trading DMTK?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2021-01-27 | Tom Malinowski | sell | $1K – $15K |
| 2021-01-11 | Tom Malinowski | buy | $1K – $15K |